| 【Company Research】I-Mab BioPharma (IMAB US) – Ph2 data of lemzoparlimab (CD47) in 1L MDS released |
| 【Fixed Income Research】HPDLF: Repayment track records count |
| 【Company Research】JNBY Design (3306 HK) – Dividend play with long-term growth potential |
| 【Company Research】Sunny Optical (2382 HK) – Soft HLS/HCM in Aug; Still awaiting turning point |
| 【Company Research】Bilibili (BILI US) – Short-term pressure from macro uncertainty |
| 【Sector Research】China Technology Sector- Apple Launch Event: new iPhone 14/Airpods/Watch inline; No price hike is the major surprise |
| 【Company Research】ClouDr (9955 HK) – Digitalizing the chronic condition management market in China |
| 【Sector Research】China Consumer Staples – A diverging 1H; mix upgrade and cost savings were keys to stay relevant |
| 【Company Research】NIO Inc. (NIO US) – Strongest 4Q22 sales volume among NEV trio |
| 【Fixed Income Research】MEITUA: Switch trade idea |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
